Turnstone Biologics Balance Sheet Health
Financial Health criteria checks 4/6
Turnstone Biologics has a total shareholder equity of $43.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $58.5M and $14.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$45.28m |
| Equity | US$43.64m |
| Total liabilities | US$14.84m |
| Total assets | US$58.48m |
Financial Position Analysis
Short Term Liabilities: TSBX's short term assets ($51.1M) exceed its short term liabilities ($13.6M).
Long Term Liabilities: TSBX's short term assets ($51.1M) exceed its long term liabilities ($1.2M).
Debt to Equity History and Analysis
Debt Level: TSBX is debt free.
Reducing Debt: TSBX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TSBX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TSBX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.3% each year